The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Genton, C.
Right arrow Articles by Acha-Orbea, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Genton, C.
Right arrow Articles by Acha-Orbea, H.
The Journal of Immunology, 2006, 177: 2285-2293.
Copyright © 2006 by The American Association of Immunologists

The Th2 Lymphoproliferation Developing in LatY136F Mutant Mice Triggers Polyclonal B Cell Activation and Systemic Autoimmunity1

Céline Genton*, Ying Wang{dagger}, Shozo Izui{ddagger}, Bernard Malissen{dagger}, Georges Delsol§, Gilbert J. Fournié||, Marie Malissen2,{dagger} and Hans Acha-Orbea2,3,*

* Department of Biochemistry, University of Lausanne, Epalinges, Switzerland; {dagger} Centre d’Immunologie de Marseille-Luminy, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de la Méditérranée, Marseille, France; {ddagger} Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; § INSERM Unité 563, Centre de Physiopathologie de Toulouse-Purpa, Toulouse, F-31300 France; Département Oncogénèse et Signalisation dans les Cellules Hématopoiétiques, Institut Fédératif de Recherche 30 and Laboratoire d’Anatomie Pathologique, Purpan’s Hospital, Toulouse F-31300, France; || INSERM Unité 563, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, F-31300 France; and # Département de Génétique Fonctionnelle des Maladies des Épithéliums, Institut Fédératif de Recherche 30, Purpan’s Hospital, Toulouse F-31300, France

LatY136F knock-in mice harbor a point mutation in Tyr136 of the linker for activation of T cells and show accumulation of Th2 effector cells and IgG1 and IgE hypergammaglobulinemia. B cell activation is not a direct effect of the mutation on B cells since in the absence of T cells, mutant B cells do not show an activated phenotype. After adoptive transfer of linker for activation of T cell mutant T cells into wild-type, T cell-deficient recipients, recipient B cells become activated. We show in vivo and in vitro that the LatY136F mutation promotes T cell-dependent B cell activation leading to germinal center, memory, and plasma cell formation even in an MHC class II-independent manner. All the plasma and memory B cell populations found in physiological T cell-dependent B cell responses are found. Characterization of the abundant plasmablasts found in secondary lymphoid organs of LatY136F mice revealed the presence of a previously uncharacterized CD93-expressing subpopulation, whose presence was confirmed in wild-type mice after immunization. In LatY136F mice, B cell activation was polyclonal and not Ag-driven because the increase in serum IgG1 and IgE concentrations involved Abs and autoantibodies with different specificities equally. Although the noncomplement-fixing IgG1 and IgE are the only isotypes significantly increased in LatY136F serum, we observed early-onset systemic autoimmunity with nephritis showing IgE autoantibody deposits and severe proteinuria. These results show that Th2 cells developing in LatY136F mice can trigger polyclonal B cell activation and thereby lead to systemic autoimmune disease.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Miyaji, R. L. Kortum, R. Surana, W. Li, K. D. Woolard, R. M. Simpson, L. E. Samelson, and C. L. Sommers
Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice
PNAS, August 25, 2009; 106(34): 14502 - 14507.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Chevrier, C. Genton, A. Kallies, A. Karnowski, L. A. Otten, B. Malissen, M. Malissen, M. Botto, L. M. Corcoran, S. L. Nutt, et al.
CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche
PNAS, March 10, 2009; 106(10): 3895 - 3900.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Archambaud, A. Sansoni, M. Mingueneau, E. Devilard, G. Delsol, B. Malissen, and M. Malissen
STAT6 Deletion Converts the Th2 Inflammatory Pathology Afflicting LatY136F Mice into a Lymphoproliferative Disorder Involving Th1 and CD8 Effector T Cells
J. Immunol., March 1, 2009; 182(5): 2680 - 2689.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Wang, A. Kissenpfennig, M. Mingueneau, S. Richelme, P. Perrin, S. Chevrier, C. Genton, B. Lucas, J. P. DiSanto, H. Acha-Orbea, et al.
Th2 Lymphoproliferative Disorder of LatY136F Mutant Mice Unfolds Independently of TCR-MHC Engagement and Is Insensitive to the Action of Foxp3+ Regulatory T Cells
J. Immunol., February 1, 2008; 180(3): 1565 - 1575.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Gorman, A. I. Russell, Z. Zhang, D. Cunninghame Graham, A. P. Cope, and T. J. Vyse
Polymorphisms in the CD3Z Gene Influence TCR{zeta} Expression in Systemic Lupus Erythematosus Patients and Healthy Controls
J. Immunol., January 15, 2008; 180(2): 1060 - 1070.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.